Silence Therapeutics plc Increase (Decrease) in Other Noncurrent Assets
Silence Therapeutics plc (SLN) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-10
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $0.00.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$257.00K, a 146.06% decline year-over-year.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$3.39M.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for fiscal 2025 was -$3.66M.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Silence Therapeutics plc increase (decrease) in other noncurrent assets for fiscal 2023 was $3.22M.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | -$257.00K derived: sum of 3 quarters · filed 2026-08-10 | -$3.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$257.00K derived: sum of 2 quarters · filed 2026-05-07 | -$3.64M derived: sum of 3 quarters · filed 2026-05-07 | -$3.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$3.64M derived: sum of 2 quarters · filed 2026-03-05 | -$3.57M derived: sum of 3 quarters · filed 2026-08-10 | -$3.66M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.31M derived: sum of 2 quarters · filed 2026-08-10 | -$3.40M 10-Q · filed 2025-11-06 | -$2.84M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$14.00K 10-Q · filed 2026-08-10 | $544.00K derived: sum of 3 quarters · filed 2026-08-10 | $263.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$89.00K 10-Q · filed 2026-05-07 | $469.00K derived: sum of 2 quarters · filed 2026-05-07 | $188.00K derived: sum of 3 quarters · filed 2026-05-07 | -$70.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $277.00K derived: sum of 2 quarters · filed 2025-11-06 | $19.00K derived: sum of 3 quarters · filed 2025-11-06 | $0.00 10-K · filed 2025-02-27 |
| 2024-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$539.00K derived: sum of 2 quarters · filed 2025-11-06 | -$558.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$258.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$277.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$19.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.22M 10-K · filed 2025-02-27 |